Developer docs
API playgroundTry for free, no card

Search company profiles

ncrad

Full company profile

uuid02m8tri

Namestring
ncrad
Legal namestring
NCRAD - National Centralized Repository for Alzheimer's Disease and Related Dementias (Indiana University School of Medicine)
Websiteurl
ncrad.org
Company typeenum
Private
Founded yearint
1990
Descriptiontext

NCRAD (National Centralized Repository for Alzheimer's Disease and Related Dementias) is a non-profit academic biorepository housed within the Indiana University School of Medicine's Department of Medical Genetics and funded by the National Institute on Aging (NIA) under cooperative grant U24 AG021886. Established in 1990, the organization provides centralized biospecimen banking, distribution, and study coordination services for Alzheimer's disease and related dementias (ADRD) research, operating from a single Indianapolis facility (351 W. 10th St TK-217).

The repository's core technology is standardized biorepository infrastructure: uniform collection, processing, storage, and distribution of biological samples — plasma, serum, DNA, RNA, CSF, PBMC, buffy coat, iPSCs/fibroblasts, and brain tissue — under harmonized Manual of Procedures and recommended consent language. NCRAD supports a genomic data processing pipeline involving HRC imputation (via University of Michigan server) and 1000 Genomes imputation (using IMPUTE2), in collaboration with ADRCs, ADGC, and NIAGADS. Three core service lines — Sample Banking, Sample Access, and Study Coordination — are supplemented by APOE genotyping, an iPSC banking initiative, a Biomarker Analysis Laboratory with cross-laboratory comparability studies, and an ADCFB data visualization tool. All sample access requires formal application, Material Transfer Agreements, and REDCap-mediated request workflows; no self-serve or API-based access exists.

NCRAD does not generate commercial revenue. Its operating model is grant-funded managed services: NIA cooperative grant funding covers biospecimen banking for participants in 90+ NIA-funded studies (ADNI, DIAN, LEADS, ADRCs, ABC-DS, ALLFTD, 90+, and others), with samples shipped globally to qualified researchers under MTA. Customer segments are academic and clinical researchers, NIA-funded studies, and (indirectly) patients and families who donate biospecimens. Strategic partners include the NIA (funder), ADRCs, ADGC, NIAGADS, NACC, and Indiana University School of Medicine as institutional operator.

Short descriptiontext

NCRAD is a non-profit, NIA-funded biorepository operated by Indiana University School of Medicine that banks and distributes standardized Alzheimer's and dementia biospecimens to researchers worldwide. It coordinates 90+ studies, has banked samples from 135K+ participants, and supports centralized sample access, study coordination, and biomarker analysis.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersIndianapolis, United States
HQ citystring
Indianapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biorepository services, biospecimen banking, Alzheimer's research samples, dementia genetic studies, biomarker analysis
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biorepository Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1NIA Cooperative Agreement Funding
TypeManaged Services
Description

NCRAD is funded by the National Institute on Aging (NIA) under cooperative grant U24 AG021886. This is government research funding, not commercial revenue.

ncrad.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NCRAD provides centralized biobanking, biospecimen distribution, and study coordination services for Alzheimer's disease and related dementias (ADRD) research. It stores and distributes biological samples (plasma, serum, DNA, RNA, CSF, PBMC, buffy coat, brain tissue, iPSCs, fibroblasts) and supports genetic, biomarker, and longitudinal cohort studies for qualified academic and clinical researchers worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 440K+ aliquots distributed to researchers worldwide
+3 more records
Product overview1 text field

NCRAD (National Centralized Repository for Alzheimer's Disease and Related Dementias) is a biorepository operated by Indiana University with NIA funding. It is not a software platform but rather a sample banking and coordination service consisting of three core offerings: Sample Banking Services (storing and distributing biospecimens), Sample Access Services (providing researchers access to cataloged samples), and Study Coordination Services (coordinating specimen collection across 90+ active studies including ADNI, LEADS, DIAN, and others). Additional offerings include the NCRAD Family Study, IU LOAD Study, APOE Genotyping, iPSC Initiative, and Biomarker Analysis Laboratory.

Product and service1 record
1Sample Banking Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCRAD collaborates with ADRCs for advancing Alzheimer's disease genetics research. ADRCs contribute participant samples and clinical data to the centralized repository.

2ADGC (Alzheimer's Disease Genetics Consortium)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration for genomic data processing and genetic research in Alzheimer's disease. ADGC provides genetics expertise and data analysis capabilities.

naccdata.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Data sharing partnership for Alzheimer's disease genetics research. NIAGADS serves as a data repository complementing NCRAD's biospecimen banking.

4NACC (National Alzheimer's Coordinating Center)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration for operational framework and data sharing protocols. NACC coordinates data collection across ADRCs and shares data with NCRAD for integrated research.

ncrad.org
Strategic tierCoreTypeOthers
Description

NCRAD is operated by Indiana University School of Medicine's Department of Medical Genetics, providing institutional infrastructure and personnel.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ncrad

Biorepository Servicesncrad.org

NCRAD is a non-profit, NIA-funded biorepository operated by Indiana University School of Medicine that banks and distributes standardized Alzheimer's and dementia biospecimens to researchers worldwide. It coordinates 90+ studies, has banked samples from 135K+ participants, and supports centralized sample access, study coordination, and biomarker analysis.

What ncrad does

NCRAD (National Centralized Repository for Alzheimer's Disease and Related Dementias) is a non-profit academic biorepository housed within the Indiana University School of Medicine's Department of Medical Genetics and funded by the National Institute on Aging (NIA) under cooperative grant U24 AG021886. Established in 1990, the organization provides centralized biospecimen banking, distribution, and study coordination services for Alzheimer's disease and related dementias (ADRD) research, operating from a single Indianapolis facility (351 W. 10th St TK-217).

The repository's core technology is standardized biorepository infrastructure: uniform collection, processing, storage, and distribution of biological samples — plasma, serum, DNA, RNA, CSF, PBMC, buffy coat, iPSCs/fibroblasts, and brain tissue — under harmonized Manual of Procedures and recommended consent language. NCRAD supports a genomic data processing pipeline involving HRC imputation (via University of Michigan server) and 1000 Genomes imputation (using IMPUTE2), in collaboration with ADRCs, ADGC, and NIAGADS. Three core service lines — Sample Banking, Sample Access, and Study Coordination — are supplemented by APOE genotyping, an iPSC banking initiative, a Biomarker Analysis Laboratory with cross-laboratory comparability studies, and an ADCFB data visualization tool. All sample access requires formal application, Material Transfer Agreements, and REDCap-mediated request workflows; no self-serve or API-based access exists.

NCRAD does not generate commercial revenue. Its operating model is grant-funded managed services: NIA cooperative grant funding covers biospecimen banking for participants in 90+ NIA-funded studies (ADNI, DIAN, LEADS, ADRCs, ABC-DS, ALLFTD, 90+, and others), with samples shipped globally to qualified researchers under MTA. Customer segments are academic and clinical researchers, NIA-funded studies, and (indirectly) patients and families who donate biospecimens. Strategic partners include the NIA (funder), ADRCs, ADGC, NIAGADS, NACC, and Indiana University School of Medicine as institutional operator.

ncrad firmographics

Firmographics
Name
ncrad
Legal name
NCRAD - National Centralized Repository for Alzheimer's Disease and Related Dementias (Indiana University School of Medicine)
Website
https://ncrad.org
Company type
Private
Founded year
1990
Operating status
Operating
Short description
NCRAD is a non-profit, NIA-funded biorepository operated by Indiana University School of Medicine that banks and distributes standardized Alzheimer's and dementia biospecimens to researchers worldwide. It coordinates 90+ studies, has banked samples from 135K+ participants, and supports centralized sample access, study coordination, and biomarker analysis.
Ownership category
akta.pro rank

Where ncrad is headquartered

Location

Headquarters

HQ city
Indianapolis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ncrad business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Others

Revenue model

  1. NIA Cooperative Agreement Funding: NCRAD is funded by the National Institute on Aging (NIA) under cooperative grant U24 AG021886. This is government research funding, not commercial revenue.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

ncrad product offering

Product offering

Core offering

NCRAD provides centralized biobanking, biospecimen distribution, and study coordination services for Alzheimer's disease and related dementias (ADRD) research. It stores and distributes biological samples (plasma, serum, DNA, RNA, CSF, PBMC, buffy coat, brain tissue, iPSCs, fibroblasts) and supports genetic, biomarker, and longitudinal cohort studies for qualified academic and clinical researchers worldwide.

Product overview

NCRAD (National Centralized Repository for Alzheimer's Disease and Related Dementias) is a biorepository operated by Indiana University with NIA funding. It is not a software platform but rather a sample banking and coordination service consisting of three core offerings: Sample Banking Services (storing and distributing biospecimens), Sample Access Services (providing researchers access to cataloged samples), and Study Coordination Services (coordinating specimen collection across 90+ active studies including ADNI, LEADS, DIAN, and others). Additional offerings include the NCRAD Family Study, IU LOAD Study, APOE Genotyping, iPSC Initiative, and Biomarker Analysis Laboratory.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sample Banking Services

Quantifiable outcome

  • 440K+ aliquots distributed to researchers worldwide
  • +3 more outcomes

Companies that use ncrad

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles1 record

ncrad technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ncrad partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • ADRCs (Alzheimer's Disease Research Centers)coreStrategic or Co-development PartnerNCRAD collaborates with ADRCs for advancing Alzheimer's disease genetics research. ADRCs contribute participant samples and clinical data to the centralized repository.
  • ADGC (Alzheimer's Disease Genetics Consortium)coreStrategic or Co-development PartnerCollaboration for genomic data processing and genetic research in Alzheimer's disease. ADGC provides genetics expertise and data analysis capabilities.
  • NIAGADS (National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site)coreStrategic or Co-development PartnerData sharing partnership for Alzheimer's disease genetics research. NIAGADS serves as a data repository complementing NCRAD's biospecimen banking.
  • NACC (National Alzheimer's Coordinating Center)coreStrategic or Co-development PartnerCollaboration for operational framework and data sharing protocols. NACC coordinates data collection across ADRCs and shares data with NCRAD for integrated research.
  • Indiana University School of MedicinecoreOthersNCRAD is operated by Indiana University School of Medicine's Department of Medical Genetics, providing institutional infrastructure and personnel.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

ncrad competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

ncrad financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ncrad leadership team

Management profile

Number of profiles

ncrad funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ncrad M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ncrad

What does ncrad do?

NCRAD provides centralized biobanking, biospecimen distribution, and study coordination services for Alzheimer's disease and related dementias (ADRD) research. It stores and distributes biological samples (plasma, serum, DNA, RNA, CSF, PBMC, buffy coat, brain tissue, iPSCs, fibroblasts) and supports genetic, biomarker, and longitudinal cohort studies for qualified academic and clinical researchers worldwide.

Is ncrad a public or private company?

ncrad is a private company. It is classified as state government owned and is currently operating.

When was ncrad founded?

ncrad was founded in 1990.

Where is ncrad based?

ncrad is headquartered in Indianapolis, United States, in the North America region.

How does ncrad make money?

One revenue line is on record: NIA Cooperative Agreement Funding.

Does ncrad have an API?

No public API is recorded for ncrad.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales